(Q34160166)

31 July 2017

1 reference

title

Re-emergence of childhood stuttering in Parkinson's disease: a hypothesis (English)

1 reference

31 July 2017

1 reference

1 reference

Shahed J

1

1 reference

31 July 2017

Jankovic J

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

16

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

114-118

1 reference

Stuttering: a review of research findings and theories circa 1982.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Predictive factors of persistence and recovery: pathways of childhood stuttering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Early childhood stuttering I: persistency and recovery rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Neurological stuttering-a clinical entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Stuttering following brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Dysfluency (stuttering) in extrapyramidal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Stuttering: disappearance and reappearance with acquired brain lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

21 January 2018

Neurogenic stuttering.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Site of penetrating brain lesions causing chronic acquired stuttering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

21 January 2018

Genetics of Stuttering

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

The genetic basis of persistence and recovery in stuttering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Developmental stuttering and Parkinson's disease: the effects of levodopa treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Speech disorders of Parkinsonism: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Speech dysfunction in early Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Regulation of parkinsonian speech volume: the effect of interlocuter distance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Stuttering may be a type of action dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Increased dopamine activity associated with stuttering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Features resembling Tourette's syndrome in developmental stutterers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

The pharmacology of stuttering: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Drug-induced stuttering: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Stuttering: neuropsychiatric features measured by content analysis of speech and the effect of risperidone on stuttering severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Clozapine-induced stuttering: epileptic brain activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Stroke-associated stuttering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Repetitive speech phenomena in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Subcortical infarction resulting in acquired stuttering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Brain correlates of stuttering and syllable production. A PET performance-correlation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

The evolution of diagnosis in early Parkinson disease. Parkinson Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Stutterers' and non-stutterers' reactions to speech situations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Delayed-onset progressive movement disorders after static brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Reemergence of stuttering after focal cerebral insult

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

Stuttering: dysfunction in a complex and dynamic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C114%3A%3AAID-MDS1004%3E3.0.CO%3B2-2

10.1002/1531-8257(200101)16:1<114::AID-MDS1004>3.0.CO;2-2

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference